- Home
- PETZ vs HOTH Comparison
PETZ vs HOTH Comparison
Compare PETZ & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- HOTH
- Stock Information
- Founded
- PETZ 2002
- HOTH 2017
- Country
- PETZ China
- HOTH United States
- Employees
- PETZ N/A
- HOTH N/A
- Industry
- PETZ Steel/Iron Ore
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- PETZ Industrials
- HOTH Health Care
- Exchange
- PETZ Nasdaq
- HOTH Nasdaq
- Market Cap
- PETZ 10.3M
- HOTH 8.3M
- IPO Year
- PETZ 2017
- HOTH 2019
- Fundamental
- Price
- PETZ $1.05
- HOTH $0.86
- Analyst Decision
- PETZ
- HOTH Strong Buy
- Analyst Count
- PETZ 0
- HOTH 3
- Target Price
- PETZ N/A
- HOTH $4.00
- AVG Volume (30 Days)
- PETZ 7.0K
- HOTH 626.4K
- Earning Date
- PETZ 05-06-2025
- HOTH 05-13-2025
- Dividend Yield
- PETZ N/A
- HOTH N/A
- EPS Growth
- PETZ N/A
- HOTH N/A
- EPS
- PETZ N/A
- HOTH N/A
- Revenue
- PETZ $3,278,453.00
- HOTH N/A
- Revenue This Year
- PETZ N/A
- HOTH N/A
- Revenue Next Year
- PETZ N/A
- HOTH N/A
- P/E Ratio
- PETZ N/A
- HOTH N/A
- Revenue Growth
- PETZ 2.46
- HOTH N/A
- 52 Week Low
- PETZ $0.99
- HOTH $0.58
- 52 Week High
- PETZ $1.74
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- PETZ 41.66
- HOTH 46.39
- Support Level
- PETZ $0.99
- HOTH $0.74
- Resistance Level
- PETZ $1.06
- HOTH $0.87
- Average True Range (ATR)
- PETZ 0.06
- HOTH 0.08
- MACD
- PETZ 0.01
- HOTH 0.01
- Stochastic Oscillator
- PETZ 37.50
- HOTH 93.30
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling of petfood and restaurant operations. The company has two operating segments which include Petfood sales and Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.